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Abstract
In the past 20 years, cold atmospheric pressure plasmas (CAPs) have become a new 
promising way for many biomedical applications, such as disinfection, cancer treatment, 
root canal treatment, wound healing, and other medical applications. Among these appli-
cations, investigations of plasma for skin wound healing has gained huge success both 
in vitro and in vivo experiments, and also the mechanism behind it has been studied by 
many groups. In this chapter, we summarize the state-of-the-art progress in wound heal-
ing by CAPs. The plasma devices developed for wound healing, the interactions between 
plasmas and microorganisms/cells/tissues, the in vitro and in vivo treatments, the clinical 
trials, and biosafety issues are all included.
Keywords: atmospheric pressure plasma, plasma devices, wound healing, disinfection, 
cell proliferation, clinical trials
1. Introduction
Wound healing is a complex process involved with infection, cell proliferation/migration, 
and skin remodeling, see Figure 1 [1]. For normal wounds, generally the first-stage inflam-
mation occurs in 24–48 h after tissue damage. Bacteria, neutrophils, and platelets are abun-
dant with normal skin appendages present outside the wound. The second stage lasts from 
after 48 h to around 10 days, during which scab would form on the skin and cell migra-
tion and proliferation vigorously occurs. New blood vessels populate the wound area. Skin 
remodeling starts in the following stage and usually lasts a year or even longer. A scar is 
usually left and the healed area does not contain normal skin appendages. Wounds can typi-
cally be categorized as acute and chronic wounds. Acute wounds contain abrasions, scalds, 
burns, or post-operative incisions; however, chronic wound does not heal in an orderly set of 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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stages and often remain in the inflammatory stage for too long and associated with systemic 
illnesses, age, and repeated trauma such as diabetic ulcers, venous ulcers, arterials ulcers, and 
pressure sores. The number of patients undergoes chronic wounds increases constantly. It 
has been reported that around 4.5–5 million people in Germany are concerned with chronic 
non-healing wounds [2]. Traditional treatments of chronic wounds are expensive and time-
consuming; patients usually undergo long-term hospitalization with a poor quality of life.
Figure 1. Classic stages of wound repair: (a) inflammation (b) new tissue formation; and (c) remodeling [1].
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The first step of chronic wound treatment begins with bacterial disinfection. However, with 
involvement of multidrug-resistant bacteria like methicillin-resistant Staphylococcus aureus 
(MRSA), treatment of chronic wound encounters more challenges, because the effect of tra-
ditional medical antiseptics is largely restrained. Therefore, there is a huge demand for new 
methods and strategies for skin disinfection and improving wound healing process. One of 
the potential candidates is cold atmospheric pressure plasmas (CAPs) [3–6].
Plasma, known as the fourth state of matter, other than plasma from blood, has been studied 
for centuries. Nevertheless, cold atmospheric pressure plasmas (CAPs) also called nonthermal 
plasmas have attracted huge attention during last two decades for its unique advantage in a new 
special field—plasma medicine. In 1996, the first paper of plasma medicine came out, which 
developed a promising way to solve the problems with traditional medical therapies [7]. Since 
then, related research groups in the entire world started to follow this new field; they extended 
the research field from initial decontamination to mechanism study, plasma cell interaction, 
cancer treatment, skin disinfection, blood coagulation, chronic wound healing, and so on, and 
since then thousands of peer-reviewed research and review papers have been published. There 
also have been various CAP devices developed [8–13], based on which, in recent years several 
commercial plasma devices have started to be used in hospital, for example, RF Argon plasma 
jet-based products by Leibniz Institute for Plasma Science and Technology (INP Greifswald)—
kINPen MED has gained Conformité Européenne (CE) marketing certification in 2013 [14].
We report the latest progress of atmospheric pressure plasma for skin wound healing in this 
chapter and the sections have been arranged as follows: in Section 2, basic plasma components 
and typical plasma sources for skin treatment are summarized; in Sections 3 and 4, funda-
mental studies of plasmas interaction with microorganism and cell/tissue are included; in 
Sections 5 and 6, in vitro and in vivo studies of CAP treatment of skin wounds on animal 
model are presented; and in Section 6, clinical trials and a very important issue—plasma 
biosafety—are presented.
2. Plasma generation and designed devices for skin disinfection
CAPs could be generated in lab using plasma source and driven by power supplies with 
working gas. Working gases such as noble gases (He, Ar), N
2
, O
2
, air, or their mixtures could 
be used to ignite the plasma. Typical constituents of plasma include electrons, ions, neutral 
particles (background gas molecules), UV radiation (UBA, UVB, UVC), heat, reactive oxy-
gen, nitrogen species (RONS), and so on (see Figure 2). All these components within plasma 
make CAPs highly reactive. The constituents and concentration of species in plasma depends 
on the plasma source, the power input as well as the working gas. When contacting with 
microorganisms or cell/tissue, components of plasma will play different roles in the treating 
processes; however, the mechanism has not been fully understood yet. It is well known that 
UVB (280–320 nm) and UVC (100–280 nm) could be able to cross the epidermis, and UVA 
(320–400 nm) can even reach the dermis. UVB and UVA can also trigger skin cancer. However, 
a lot of reports claimed that UV radiation in plasma is low and does not play a significant 
role in anti-microorganism process except that from microwave-driven discharge [15–18]. 
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Charged particles in plasma were concluded to play an essential role in bacterial inactivation 
by rupturing the outer layer of cell membrane [19, 20]. Mendis et al. reported the electro-
static force caused by charge accumulation on the cell membrane could overcome the tensile 
strength which leads to rupture [15]. However, other researchers claimed different viewpoints 
that the anti-bacterial effect of the charged particles is due to the chemical modification of 
the membrane surface [21]. CAPs are usually designed to operate in near room temperature 
(less than 40°C); therefore, there would not be substantial thermal effects on microbial cells 
[22]. The effect of heat can be ignored. The microorganism is under indirect plasma treatment 
which means that plasma does not directly contact with the target; the electric field was too 
weak to contribute to the inactivation process. In some cases, when plasma is in direct contact 
with the samples, the electric field could become high enough to take effect [23]. However, 
in most of the cases, there is a rare possibility to put the samples within 300 μm away from 
the electrode to cause damage by the electric field [24]. If the plasma device is using air or O
2
-
containing mixture or operating in the open air, RONS such as O, O
3
, NO, NO
2
, OH, and H
2
O
2
 
would present. These highly active species are believed to play an important role in all the 
plasma treatment processes and have already been reported by many researchers [18, 26–28]. 
The detailed discussion of the roles of reactive species can be found in [29].
Figure 2. Plasma components.
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Figure 3 summarizes several typical plasma sources used in different research groups. (a) is 
called plasma pencil designed by Laroussi group [30]. This device driven by sub-microsecond 
high-voltage pulse uses He gas flowing through a modified DBD device (with holes in the center 
of dielectric plates), therefore the plasma created between electrode panels comes out and forms 
a plasma plume up to 5 cm. Another famous plasma source construct is a floating-electrode 
DBD device (FE-DBD) which uses the treating object as the second electrode and could gener-
ate plasma between the electrode surface and the substrate [31]. FE-DBD could directly use the 
air inside the short gap as working gas. Safety and stability of FE-DBD largely depends on the 
power supply, the gas gap, and the electrode shape. Kolb et al. introduced a DC-driven micro-
hollow cathode discharge to generate plasma plume outside the tiny hole (c) [32]. It could use 
air or other gas as working gas. A 51 KΩ ballast resistor is connected to the circuit to restrain the 
current to 20 mA. The dimension of the plume changes with the gas flow rate as well as the gas 
temperature. Lu et al. reported a single-electrode plasma jet powered by nanosecond pulse DC 
[33]. Helium is used as working gas and the length of plasma plume could reach up to 4 cm. The 
gas temperature is about 300 K and species like O, OH, and N
2
+ are all detected by optical emis-
sion spectra (OES) (d). Another structure called plasma needle usually uses bare metal needle 
as electrode, see (e) and (f) [9, 34]. (g) is a portable DC-driven plasma needle array device called 
plasma flashlight [35]. This device can directly use a DC battery to power up and create plasma 
in the open air. (h) is a plasma brush of relatively large area [36]. (i) is also a classical design 
Figure 3. Typical CAP sources.
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(surface micro-discharge, SMD) representing ‘indirect plasma’ [37]. This type of plasma gener-
ates on the surface of the electrode, and the plasma does not directly contact with the treatment 
target. When using air as working gas, SMD could operate in three modes: call ozone mode, tran-
sition mode, and NOx mode, respectively. The transition between these modes depends on the 
input power. More detailed information of the different plasma sources can be found in [38, 39].
With the development of the lab-made plasma sources and fundamental studies, many 
commercial plasma device products have been delivered into the market. Figure 4 shows 
three famous products for skin wound healing based on plasma jet device, FE-DBD and 
SMD, respectively. Figure 4(a) is the world famous kINPen plasma device, which is based 
on a RF argon plasma jet source and gained CE marketing certification in 2013. (b) is 
called PlasmaDerm based on FE-DBD. And (c) is MicroPlasma β, which origins from SMD 
device. The wound healing effect of these three products will be presented in the following 
sections.
3. Plasma interaction with microorganisms
Plasma sterilization is the first research field of plasma medicine. Since Professor Laroussi 
published the first paper of plasma sterilization in 1996 on IEEE Transactions on Plasma Science 
[7], there came out thousands of studies on inactivation of bacteria, fungi, and virus using 
different plasma sources. At the same time, mechanism of plasma interaction with micro-
organism was studied by using physical, chemical, and biomedical diagnostic methods, 
such as optical emission spectra (OES), laser-induced fluorescence (LIF), Fourier transform 
infrared spectroscopy (FTIR), flow cytometry, electrophoresis, ELISA, chemiluminescence 
assay, and so on. However, the exact mechanism of plasma inactivation microorganisms still 
Figure 4. Three commercialized CAPs medical devices.
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remains unclear. Possible mechanisms proposed by researchers are: (1) electroporation- and 
oxidation-induced cell wall/membrane dysfunction, which leads to leakage of cellular com-
ponents; (2) intracellular oxidation and nitrification causing protein damage and gene expres-
sion disorder; and (3) direct DNA damage such as causing double-strand breaking.
Bacterial killing effect by CAPs has been investigated for more than 20 years. It is found that CAPs 
could effectively inactivate different type of bacteria, including gram-positive and gram-nega-
tive, anaerobic, aerobic, or facultative anaerobic bacteria [40]. The response of bacteria to CAPs 
is species-dependent and the Gram-positive bacteria is usually more susceptible to CAPs treat-
ment because of the difference of cell-wall components, which indicates that the CAP-induced 
damage to the cell membrane and cell wall may be a key factor of antibacterial effect. The most 
common bacteria found in skin and wound infection are Staphylococcus aureus, Staphylococcus 
epidermidis, Bacillus cereus, and so on, which have been proved to be effectively inactivated by 
CAPs [41, 42]. Unlike drugs, another advantage of CAPs is that plasma does not show any resis-
tance after multi-treatment against bacteria. Maisch et al. reported significant decolonization of 
methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli without cell damage of a 
pig skin sample [43]. Alkawareek et al. also found complete inactivation of MRSA [44].
Many fungi are common constituents of skin flora, and under certain conditions, they would 
cause diseases. The effects of traditional tools such as chemicals, UV radiation, or heat are often 
unsatisfactory and sometimes accompanied by undesirable side effects. Unlike bacteria, fun-
gus is more resistance to plasma treatment because of the much more complex cell biology. In 
2008, Akishev et al. published the first paper of CAP decontamination of Aspergillus niger and 
Candida lipolytica on agar surface using N
2
 + O
2
 plasma jet. After 30–60 treatments, inhibition 
zone of 30–40 mm was observed [45]. Xiong et al. also inactivated Candida albicans on agar sur-
face using a He + O
2
 plasma jet [46]. They compared the antifungal effect of with/without a cap 
on the petri dish and found that restraining active species inside the chamber largely improved 
the antifungal effect. Daeschlein et al. used a low-temperature atmospheric pressure plasma 
jet to treat clinical isolates of Trichophyton interdigitale, Trichophyton rubrum, Microsporum canis, 
and Candida albicans. They found that plasma irradiation could eradicate fungal growth and 
no isolate exhibited resistance to plasma treatment [47]. In a new research area of plasma treat-
ment of onychomycosis, Xiong et al. used three kinds of CAPs to treat E. coli and Trichophyton 
rubrum living on the back side of a nail model and found that bacteria is easier to inactivate 
than fungus and the inactivation effect also related to the structure of plasma sources [48].
Researchers also use CAPs successfully inactivate various virus and mechanism has been 
investigated as well [49–51].
It is known that more than 60% of all infections are caused by bacteria in the form of bacteria 
which could become resistant to treatment and often develop into a chronic state. A biofilm is 
often formed by a cluster of cells encapsulated by a 3D extracellular matrix (ECM), [52] which 
forms a good protection barrier for antibiotics and plasma agents. Therefore, cells inside this 
community have been demonstrated to exhibit higher antibiotic resistance than planktonic 
cells. However, CAPs have also shown great decontamination effect against biofilms with 
longer time than treating planktonic cells under same condition [53, 54]. Koban et al. com-
pared the anti-biofilm (Candida albicans) effect by dielectric barrier discharge and plasma jet, 
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and used 0.1% chlorhexidine digluconate (CHX) and 0.6% sodium hypochlorite (NaOCl) as 
positive control. They found plasma treatment reduced the colony-forming units CFU signifi-
cantly compared to chemical disinfectants [55]. In a later research, they investigated the syn-
ergistic effect of nonthermal plasma and disinfecting agents against single and multispecies 
dental biofilms. They found that the combination of plasma and agents increases the antimi-
crobial efficacy of all tested compounds [56]. Xiong et al. firstly used Laser Confocal Scanning 
Microscopy (LCSM) technology to obtain the depth of biofilm that plasma could penetrate 
through [57]. A He-O
2
 mixture nanosecond pulse DC-driven plasma jet was used to treat a 
10-day growth of Porphyromonas gingivalis biofilm, and found that 5-min plasma treatment 
could at least inactivate the bacteria under 15 μm. In their following work, they successfully 
inactivated a 25.5 μm biofilm using a plasma flashlight [35]. Puligundla and Mok reviewed 
the potential application of nonthermal plasmas against biofilm-associated microorganism in 
2017. For more details about plasma interaction with biofilms, refer [58].
4. Plasma interaction with skin-related cells/tissues in vitro
The interaction between plasma and human cells largely depends on the plasma source, plasma 
doses as well as cell type. Researches on plasma cells interaction have been studied by several 
groups [59–61]. For a unique mixed state with electrical field, charged particles, and control-
lable reactive species, the response of eukaryotic cell to plasma treatment is very different. It is 
generally accepted that low dose of plasma treatment could stimulate cell viability and enhance 
proliferation, differentiation, and migration, while high dose induces cell apoptosis/necrosis 
[62–65]. It has been found that the resistance against plasma treatment is different between 
cancer cells and normal cells, which makes plasma selectively killing cancer cells while bring 
less damage to normal cells and become a potential and powerful tool against cancers [66–68].
Figure 5. The progression and statistical analyses of cell migration or coverage, 6 and 12 h after plasma exposure times 
of 5, 10, and 15 s [71].
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As mentioned earlier, the second stage of wound repair is related to cell proliferation and 
migration as well as angiogenesis. Cell types involved in wound healing are mainly fibroblasts 
and keratinocytes, among which keratinocytes contribute to the major healing processes and 
fibroblast cells play a guiding role [69, 70]. It has already been reported that CAPs could 
increases fibroblast cell proliferation and migration by using N
2
/Ar microplasma through 
simulated release of fibroblast growth factor-7 [71], as seen in Figure 5. Researchers from INP 
Figure 6. (a) Non-invasive angiographic OCT images and (b) stereoscopic images longitudinally acquired over 14 days 
after wound generation; relative depth in angiographic OCT images is color-coded as from yellow (superficial) to red 
(deep) [82].
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have done series of investigations of plasma interaction of keratinocyte. They used different 
plasma sources including plasma jet (kINPen), SMD and DBD, and different keratinocyte 
cell models/tissues to study the response after treatment. They found increased b1-integrin 
expression and reduced E-cadherin and EGFR expression of HaCaT-keratinocytes after 30 s 
treatment [72]. Intracellular level of ROS increased after SMD treatment without dependence 
on the treatment time or different treatment regimens [73] and DBD and kINPen 09 plasma 
treatments could also induce oxidative stress in human keratinocytes [71, 72]. Plasma treat-
ment could not only induce cell reactions of stress-sensing but also of proliferative nature, and 
they propose that stimulating doses of plasma treatment may protect epithelial skin cells in 
wound healing by promoting proliferation and differentiation through triggering hormesis-
like processes [74–78]. Other groups also found the evidence that short-term plasma exposure 
could enhance keratinocyte proliferation [79].
Angiogenesis is a very important process in the second stage of wound healing involving 
with growth factors, cytokines, ROS, and NO which could be provided by CAPs. Studies of 
plasma-inducing angiogenesis have been reported by many groups. Arjunan et al. found that 
FE-DBD treatment could induce angiogenesis by FGF-2 release regulated by plasma-produced 
ROS [80]. Hirata et al. used a mouse burn model to investigate the healing process by plasma 
irradiation, and they found that healing process was improved and the quantity of neovas-
cular vessels was increased after plasma treatment [81]. Kim et al. used angiographic optical 
coherence tomography (OCT), which successfully captured the plasma-induced angiogenesis 
process. Figure 6 shows the en face vascular projections acquired from the angiographic OCT 
and matched stereoscopic images of the plasma and control wounds over 14 days. They found 
that the vascular wound area decease of plasma treated wound was more significant [82]. Up 
to date, very little is known about plasma-induced angiogenesis formation and a lot of work 
needs to be done in the future to understand the mechanism of plasma effect on angiogenesis.
5. CAPs treatment of in vivo animal m`odels
Based on previous fundamental research of plasma treatment on would healing, treatments 
on animal models with various wounds and clinical trials are also conducted. Ermolaeva 
et al. used an argon plasma, which tested the antibacterial effect on both vitro and on the ani-
mal model of infected wounds. They found that the 10-min treatment significantly reduced 
bacterial loads on wound surface and 5-day daily plasma treatment could eliminate bacte-
ria from the infected surface 2 days earlier than the control. Wound closure was accelerated 
in the plasma-treated animals [41]. Nastuta et al. established a burned wounds model on 
Wistar rat’s skin and used a helium plasma jet to stimulate the wound healing process. They 
found that both polyurethane wound dressing and plasma-assisted epithelization are posi-
tive for the recovery process of burned wounds [83]. Alcantara et al. and Hung et al. also 
found accelerated wound healing after argon and helium plasma needle and plasma jet treat-
ment [84, 85]. Anke Schmidt used kINPen argon plasma jet device to investigate the wound 
healing activity on a murine model of full-thickness ear wound; a significant acceleration of 
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wound re-epithelization was observed in days 3–9 [86]. Same results were found by Kubinova 
et al. without noticeable effects and concomitant activation of pro-inflammatory signaling 
[87]. Shao et al. investigated the efficacy of a nonthermal N
2
/Ar treatment of a laser-induced 
partial thickness skin wound on a mouse model. Wound-closure kinetics, optical coherence 
tomography (OCT) and laser Doppler scanning methods were used to measure the healing 
efficiency and results also show the promotion of wound healing by micro-plasma treatment 
[88]. Wound healing process in diabetic patients is relatively slow and current therapeutic 
methods are not completely successful. Fathollah et al. studied the wound healing process by 
plasma in diabetic rats and found enhanced wound healing rate in the nondiabetic rats and 
significant wound contraction in diabetic rats after plasma treatment, as seen in Figure 7. And 
also histological analyses show the formation of epidermis layer, neovascularization, and cell 
proliferation [89].
Figure 7. Wound observation for days 3, 7, 15 and 30 after the treatment [89].
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6. Clinic trials and biosafety concern
Beside animal studies, clinical trials have also been done on patients, especially by using 
several commercialized products. The world’s first plasma source used for clinical trials 
was the microwave plasma torch MicroPlaSter. Using the first-generation product named 
MicroPlaSter α, they treated 38 chronic infected wounds on 36 patients with 291 5-min daily 
treatments and standard wound care, and obtained a significant reduction (34%) of bacterial 
load without any side effects [90]. In the following study, they compared plasma treatment 
on various etiologies (Group A), all chronic ulcers (Group B) and Group C for 5-min plasma 
treatment of chronic venous ulcers. They found a greater reduction in width and length in 
Group A than control. In Groups B and C, significant reduction in width was found with 
plasma treatment but not in length [91]. Figure 8 shows a modified version of MicroPlaSter 
β and results of treating inflamed ulcer [92]. Isbary et al. reported a successful treatment of 
Figure 8. Inflamed ulcer of the right lower leg treatment with cold atmospheric argon plasma generated by MicroPlaSter 
β [92].
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Hailey-Hailey disease by a daily 5-min cold plasma treatment and significant improvement 
was found after 11 treatments [93]. The argon plasma jet device kINPen MED and DBD 
plasma source PlasmaDerm successively got the CE marketing for medical devices in 2013. 
Based on the previous fundamental studies in vitro and on animals, they both reported series 
clinical trials on human beings focusing on wound healing treatment, especially for the treat-
ment of chronic/infected wounds and microorganism-caused skin diseases. For example, 
PlasmaDerm was reported to reduced more than tenfold in bacterial colonization on an 
adult patient with atopic eczema by 30-day treatment of 1 min/day [94]. kINPen MED was 
reported to significantly reduce the wound volume compared to octenisept in 16 patients 
with ulcer [95].
Plasma biosafety is definitely a big issue in clinical application. Both of these commercial-
ized products showed tolerable properties (temperature, UV radiation, reactive species, 
electrical currents, mutagenicity, penetration depth, subjective sensations, cytotoxicity, and 
histocompatibility) on human skin under controlled conditions and exhibited accelerated 
wound healing rate [95–98]. Systematic review work of these two devices could be found 
in [14, 92].
7. Conclusion
Atmospheric pressure cold plasmas could affect different stages of wound healing by helping 
to activate microorganisms in the first stage and stimulate skin-related cell proliferation and 
migration in the following period. CAPs have demonstrated high wound healing abilities and 
may become a promising therapy to replace or assist traditional methods in clinics for wound 
healing process, especially in chronic wounds. With the certification of several CAP prod-
ucts, more standards and procedures for clinical treatments should be cleared in the future to 
guide the plasma treatment under an effective and safe way.
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